CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +239 | 1,896.89 | ||
| 2022-04-01 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −84 | $210.65 | $18K | 1,812.89 |
| 2022-04-01 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −239 | 479 | ||
| 2022-02-18 | Vounatsos Michel Chief Executive Officer | Option exercise | +6,191 | 70,007.19 | ||
| 2022-02-18 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,746 | $209.79 | $576K | 67,261.19 |
| 2022-02-18 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,191 | 39,119 | ||
| 2022-02-18 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −8,909 | 30,210 | ||
| 2022-02-18 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +371 | 1,767.89 | ||
| 2022-02-18 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −110 | $209.79 | $23K | 1,657.89 |
| 2022-02-18 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −371 | 2,349 | ||
| 2022-02-18 | Murphy Nicole Head of Pharm Ops and Tech | Other disposition · Restricted Stock Unit | −535 | 1,814 | ||
| 2022-02-18 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +1,981 | 5,404 | ||
| 2022-02-18 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −977 | $209.79 | $205K | 4,427 |
| 2022-02-18 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −1,981 | 12,519 | ||
| 2022-02-18 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Other disposition · Restricted Stock Unit | −2,851 | 9,668 | ||
| 2022-02-18 | Kramer Robin Chief Accounting Officer | Option exercise | +396 | 1,854.35 | ||
| 2022-02-18 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −117 | $209.79 | $25K | 1,737.35 |
| 2022-02-18 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −396 | 2,504 | ||
| 2022-02-18 | Kramer Robin Chief Accounting Officer | Other disposition · Restricted Stock Unit | −570 | 1,934 |
Page 29 of 29 · 579 trades